Attached files
| file | filename |
|---|---|
| EX-4.5 - EX-4.5 - Verona Pharma plc | vrna-descriptionofsecuriti.htm |
| EX-32.2 - EX-32.2 - Verona Pharma plc | exhibit322.htm |
| EX-32.1 - EX-32.1 - Verona Pharma plc | exhibit321.htm |
| EX-31.2 - EX-31.2 - Verona Pharma plc | exhibit312.htm |
| EX-31.1 - EX-31.1 - Verona Pharma plc | exhibit311.htm |
| EX-10.19.2 - EX-10.19.2 - Verona Pharma plc | svb-firstamendmenttoloan.htm |
| EX-10.20 - EX-10.20 - Verona Pharma plc | non-executicedirectorappoi.htm |
| 10-K - 10-K - Verona Pharma plc | vrna-20201231.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-248199, 333-237926, 333-217521) of Verona Pharma Plc of our report dated February 25, 2021 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Reading, United Kingdom
February 25, 2021